Advancing New Pharma: Aseptic filling of bags
With baXeptic, Harro Höfliger has developed a new platform technology for the aseptic filling of complex products into pre-sterilized bags.
Biopharmaceuticals and infusion therapies, for example with gene and cell-based active ingredients, have what it takes to revolutionize the pharmaceutical market. However, these complex, intravenously administered products must not be terminally sterilized after being filled into bags. With baXeptic, Harro Höfliger now offers a tailor-made system solution for the demanding aseptic filling of these substances into pre-sterilized bags. Hygienic design is the top priority, perfectly tailored to the individual product and the customer's requirements. The systems comply with the new EU GMP Annexe 1 for the manufacture of sterile products and with FDA requirements.
baXeptic will be launched at the leading trade fair Achema in Frankfurt (August, 22 to 26, 2022)
Find out more about individually configured systems for aseptic production environments here: https://baxeptic.hoefliger.com/en/